Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.

Semenova S, Jin X, McClure-Begley TD, Tadman MP, Marks MJ, Markou A.

Pharmacol Biochem Behav. 2018 Aug;171:54-65. doi: 10.1016/j.pbb.2018.06.002. Epub 2018 Jun 14.

PMID:
29908200
2.

Manipulating the Alpha Level Cannot Cure Significance Testing.

Trafimow D, Amrhein V, Areshenkoff CN, Barrera-Causil CJ, Beh EJ, Bilgiç YK, Bono R, Bradley MT, Briggs WM, Cepeda-Freyre HA, Chaigneau SE, Ciocca DR, Correa JC, Cousineau D, de Boer MR, Dhar SS, Dolgov I, Gómez-Benito J, Grendar M, Grice JW, Guerrero-Gimenez ME, Gutiérrez A, Huedo-Medina TB, Jaffe K, Janyan A, Karimnezhad A, Korner-Nievergelt F, Kosugi K, Lachmair M, Ledesma RD, Limongi R, Liuzza MT, Lombardo R, Marks MJ, Meinlschmidt G, Nalborczyk L, Nguyen HT, Ospina R, Perezgonzalez JD, Pfister R, Rahona JJ, Rodríguez-Medina DA, Romão X, Ruiz-Fernández S, Suarez I, Tegethoff M, Tejo M, van de Schoot R, Vankov II, Velasco-Forero S, Wang T, Yamada Y, Zoppino FCM, Marmolejo-Ramos F.

Front Psychol. 2018 May 15;9:699. doi: 10.3389/fpsyg.2018.00699. eCollection 2018. Review.

3.

The interaction of the Chrna5 D398N variant with developmental nicotine exposure.

O'Neill HC, Wageman CR, Sherman SE, Grady SR, Marks MJ, Stitzel JA.

Genes Brain Behav. 2018 Sep;17(7):e12474. doi: 10.1111/gbb.12474. Epub 2018 Apr 17.

PMID:
29573323
4.

Deletion of lynx1 reduces the function of α6* nicotinic receptors.

Parker RL, O'Neill HC, Henley BM, Wageman CR, Drenan RM, Marks MJ, Miwa JM, Grady SR, Lester HA.

PLoS One. 2017 Dec 5;12(12):e0188715. doi: 10.1371/journal.pone.0188715. eCollection 2017.

5.

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Wall TR, Henderson BJ, Voren G, Wageman CR, Deshpande P, Cohen BN, Grady SR, Marks MJ, Yohannes D, Kenny PJ, Bencherif M, Lester HA.

Front Pharmacol. 2017 Sep 26;8:641. doi: 10.3389/fphar.2017.00641. eCollection 2017.

6.

Reduced α4 subunit expression in α4+- and α4+- /β2+- nicotinic acetylcholine receptors alters α4β2 subtype up-regulation following chronic nicotine treatment.

Moretti M, Fasoli F, Gotti C, Marks MJ.

Br J Pharmacol. 2018 Jun;175(11):1944-1956. doi: 10.1111/bph.13896. Epub 2017 Aug 1.

7.

Density functional theory study of mechanism of epoxy-carboxylic acid curing reaction.

Ly UQ, Pham MP, Marks MJ, Truong TN.

J Comput Chem. 2017 May 30;38(14):1093-1102. doi: 10.1002/jcc.24779.

PMID:
28409848
8.

Gender Role Violations and the Sexual Double Standard.

Zaikman Y, Marks MJ, Young TM, Zeiber JA.

J Homosex. 2016 Dec;63(12):1608-1629. Epub 2016 Mar 1.

PMID:
26930471
9.

Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex.

McClure-Begley TD, Esterlis I, Stone KL, Lam TT, Grady SR, Colangelo CM, Lindstrom JM, Marks MJ, Picciotto MR.

eNeuro. 2016 Aug 16;3(4). pii: ENEURO.0166-16.2016. doi: 10.1523/ENEURO.0166-16.2016. eCollection 2016 Jul-Aug.

10.

Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.

Ondachi PW, Castro AH, Luetje CW, Wageman CR, Marks MJ, Damaj MI, Mascarella SW, Navarro HA, Carroll FI.

ACS Chem Neurosci. 2016 Jul 20;7(7):1004-12. doi: 10.1021/acschemneuro.6b00107. Epub 2016 May 19.

PMID:
27166021
11.

In vivo chronic nicotine exposure differentially and reversibly affects upregulation and stoichiometry of α4β2 nicotinic receptors in cortex and thalamus.

Fasoli F, Moretti M, Zoli M, Pistillo F, Crespi A, Clementi F, Mc Clure-Begley T, Marks MJ, Gotti C.

Neuropharmacology. 2016 Sep;108:324-31. doi: 10.1016/j.neuropharm.2016.04.048. Epub 2016 May 6.

PMID:
27157710
12.

Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.

Pistillo F, Fasoli F, Moretti M, McClure-Begley T, Zoli M, Marks MJ, Gotti C.

Pharmacol Res. 2016 Jan;103:167-76. doi: 10.1016/j.phrs.2015.11.016. Epub 2015 Nov 26.

PMID:
26631628
13.

Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice.

Locker AR, Marks MJ, Kamens HM, Klein LC.

Brain Res Bull. 2016 May;123:13-22. doi: 10.1016/j.brainresbull.2015.09.009. Epub 2015 Sep 30.

14.

Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.

Marks MJ, O'Neill HC, Wynalda-Camozzi KM, Ortiz NC, Simmons EE, Short CA, Butt CM, McIntosh JM, Grady SR.

Neuropharmacology. 2015 Dec;99:142-55. doi: 10.1016/j.neuropharm.2015.07.019. Epub 2015 Jul 17.

15.

In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.

Carroll FI, Navarro HA, Mascarella SW, Castro AH, Luetje CW, Wageman CR, Marks MJ, Jackson A, Damaj MI.

ACS Chem Neurosci. 2015 Jun 17;6(6):920-6. doi: 10.1021/acschemneuro.5b00077. Epub 2015 Apr 30.

16.

Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure.

Zambrano CA, Short CA, Salamander RM, Grady SR, Marks MJ.

Pharmacol Res Perspect. 2015 Mar;3(2):e00111. doi: 10.1002/prp2.111.

17.

Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.

Meyers EE, Loetz EC, Marks MJ.

Pharmacol Biochem Behav. 2015 Mar;130:1-8. doi: 10.1016/j.pbb.2014.12.013. Epub 2015 Jan 3.

18.

Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.

Stoker AK, Marks MJ, Markou A.

Eur J Pharmacol. 2015 Apr 15;753:146-50. doi: 10.1016/j.ejphar.2014.05.062. Epub 2014 Aug 5.

19.

Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.

Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI.

Neuropsychopharmacology. 2015 Jan;40(2):350-60. doi: 10.1038/npp.2014.177. Epub 2014 Jul 18.

20.

Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes.

McClure-Begley TD, Grady SR, Marks MJ, Collins AC, Stitzel JA.

Biochem Pharmacol. 2014 Sep 1;91(1):87-96. doi: 10.1016/j.bcp.2014.06.010. Epub 2014 Jun 19.

21.

Density functional theory study on mechanisms of epoxy-phenol curing reaction.

Pham MP, Pham BQ, Huynh LK, Pham HQ, Marks MJ, Truong TN.

J Comput Chem. 2014 Aug 15;35(22):1630-40. doi: 10.1002/jcc.23658. Epub 2014 Jun 16.

PMID:
24935159
22.

α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.

Marks MJ, Grady SR, Salminen O, Paley MA, Wageman CR, McIntosh JM, Whiteaker P.

J Neurochem. 2014 Jul;130(2):185-98. doi: 10.1111/jnc.12721. Epub 2014 Apr 19.

23.

Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.

Stevens KE, Choo KS, Stitzel JA, Marks MJ, Adams CE.

Brain Res. 2014 Mar 13;1552:26-33. doi: 10.1016/j.brainres.2014.01.022. Epub 2014 Jan 23.

24.

Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.

Wageman CR, Marks MJ, Grady SR.

Nicotine Tob Res. 2014 Mar;16(3):297-305. doi: 10.1093/ntr/ntt146. Epub 2013 Sep 19.

25.

Exploring the nicotinic acetylcholine receptor-associated proteome with iTRAQ and transgenic mice.

McClure-Begley TD, Stone KL, Marks MJ, Grady SR, Colangelo CM, Lindstrom JM, Picciotto MR.

Genomics Proteomics Bioinformatics. 2013 Aug;11(4):207-18. doi: 10.1016/j.gpb.2013.05.005. Epub 2013 Jul 25.

26.

Impaired hippocampal theta oscillations in the mice null alpha7 nicotinic acetylcholine receptors.

Jin Y, Su QX, Shen JX, Marks MJ, Wu J.

CNS Neurosci Ther. 2013 Sep;19(9):721-3. doi: 10.1111/cns.12138. Epub 2013 Jun 25. No abstract available.

27.

Attachment-related individual differences in the consistency of relationship behavior interpretation.

Marks MJ, Trafimow D, Rice SC.

J Pers. 2014 Jun;82(3):237-49. doi: 10.1111/jopy.12048. Epub 2013 Aug 5.

PMID:
23750636
28.

Genetic matters: thirty years of progress using mouse models in nicotinic research.

Marks MJ.

Biochem Pharmacol. 2013 Oct 15;86(8):1105-13. doi: 10.1016/j.bcp.2013.05.021. Epub 2013 Jun 6. Review.

29.

A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.

Soll LG, Grady SR, Salminen O, Marks MJ, Tapper AR.

Neuropharmacology. 2013 Oct;73:19-30. doi: 10.1016/j.neuropharm.2013.05.001. Epub 2013 May 17.

30.

Adaptive memory: evaluating alternative forms of fitness-relevant processing in the survival processing paradigm.

Sandry J, Trafimow D, Marks MJ, Rice S.

PLoS One. 2013 Apr 9;8(4):e60868. doi: 10.1371/journal.pone.0060868. Print 2013.

31.

Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function.

O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, McIntosh JM, Lindstrom JM, Lester HA, Grady SR, Marks MJ.

Pharmacol Biochem Behav. 2013 Jan;103(3):603-21. doi: 10.1016/j.pbb.2012.10.014. Epub 2012 Nov 1.

32.

CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.

Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, Zoli M, Tasso B, Sparatore F, Clementi F, Gotti C.

Br J Pharmacol. 2013 Feb;168(4):835-49. doi: 10.1111/j.1476-5381.2012.02204.x.

33.

α6* nicotinic acetylcholine receptor expression and function in a visual salience circuit.

Mackey ED, Engle SE, Kim MR, O'Neill HC, Wageman CR, Patzlaff NE, Wang Y, Grady SR, McIntosh JM, Marks MJ, Lester HA, Drenan RM.

J Neurosci. 2012 Jul 25;32(30):10226-37. doi: 10.1523/JNEUROSCI.0007-12.2012.

34.

Characterization of 4-HNE modified L-FABP reveals alterations in structural and functional dynamics.

Smathers RL, Fritz KS, Galligan JJ, Shearn CT, Reigan P, Marks MJ, Petersen DR.

PLoS One. 2012;7(6):e38459. doi: 10.1371/journal.pone.0038459. Epub 2012 Jun 6.

35.

Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures.

Zambrano CA, Salamander RM, Collins AC, Grady SR, Marks MJ.

J Pharmacol Exp Ther. 2012 Aug;342(2):245-54. doi: 10.1124/jpet.112.192542. Epub 2012 Apr 24.

36.

A novel α-conotoxin MII-sensitive nicotinic acetylcholine receptor modulates [(3) H]-GABA release in the superficial layers of the mouse superior colliculus.

McClure-Begley TD, Wageman CR, Grady SR, Marks MJ, McIntosh JM, Collins AC, Whiteaker P.

J Neurochem. 2012 Jul;122(1):48-57. doi: 10.1111/j.1471-4159.2012.07759.x. Epub 2012 May 9.

37.

Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.

Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ.

J Neurosci. 2012 Feb 15;32(7):2352-6. doi: 10.1523/JNEUROSCI.4985-11.2012.

38.

The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.

Gould TJ, Portugal GS, André JM, Tadman MP, Marks MJ, Kenney JW, Yildirim E, Adoff M.

Neuropharmacology. 2012 Apr;62(5-6):2118-25. doi: 10.1016/j.neuropharm.2012.01.003. Epub 2012 Jan 21.

39.

Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.

Ortiz NC, O'Neill HC, Marks MJ, Grady SR.

Nicotine Tob Res. 2012 Jun;14(6):711-9. doi: 10.1093/ntr/ntr284. Epub 2012 Jan 12.

40.

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release.

Grady SR, Wageman CR, Patzlaff NE, Marks MJ.

Neuropharmacology. 2012 Apr;62(5-6):1935-43. doi: 10.1016/j.neuropharm.2011.12.026. Epub 2012 Jan 2.

41.

Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects.

Gallego X, Molas S, Amador-Arjona A, Marks MJ, Robles N, Murtra P, Armengol L, Fernández-Montes RD, Gratacòs M, Pumarola M, Cabrera R, Maldonado R, Sabrià J, Estivill X, Dierssen M.

Amino Acids. 2012 Aug;43(2):897-909. doi: 10.1007/s00726-011-1149-y. Epub 2011 Nov 19.

PMID:
22101982
42.

Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.

Cohen BN, Mackey ED, Grady SR, McKinney S, Patzlaff NE, Wageman CR, McIntosh JM, Marks MJ, Lester HA, Drenan RM.

Neuroscience. 2012 Jan 3;200:31-41. doi: 10.1016/j.neuroscience.2011.10.047. Epub 2011 Nov 4.

43.

An empirically derived approach to the latent structure of the Adult Attachment Interview: additional convergent and discriminant validity evidence.

Haydon KC, Roisman GI, Marks MJ, Fraley RC.

Attach Hum Dev. 2011 Sep;13(5):503-24. doi: 10.1080/14616734.2011.602253.

44.

Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice.

Kota D, Sanjakdar S, Marks MJ, Khabour O, Alzoubi K, Damaj MI.

Biochem Pharmacol. 2011 Oct 15;82(8):1008-14. doi: 10.1016/j.bcp.2011.06.019. Epub 2011 Jun 25.

45.

An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants.

Baddick CG, Marks MJ.

Biochem Pharmacol. 2011 Oct 15;82(8):828-41. doi: 10.1016/j.bcp.2011.04.019. Epub 2011 May 10.

46.

Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area.

Zhao-Shea R, Liu L, Soll LG, Improgo MR, Meyers EE, McIntosh JM, Grady SR, Marks MJ, Gardner PD, Tapper AR.

Neuropsychopharmacology. 2011 Apr;36(5):1021-32. doi: 10.1038/npp.2010.240. Epub 2011 Feb 2.

47.

Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ.

Nature. 2011 Mar 31;471(7340):597-601. doi: 10.1038/nature09797. Epub 2011 Jan 30.

48.

Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.

Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM.

J Pharmacol Exp Ther. 2011 Apr;337(1):187-200. doi: 10.1124/jpet.110.178236. Epub 2011 Jan 12.

49.

Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors.

Heath CJ, King SL, Gotti C, Marks MJ, Picciotto MR.

Neuropsychopharmacology. 2010 Nov;35(12):2324-38. doi: 10.1038/npp.2010.130. Epub 2010 Aug 25.

50.

Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Drenan RM, Grady SR, Steele AD, McKinney S, Patzlaff NE, McIntosh JM, Marks MJ, Miwa JM, Lester HA.

J Neurosci. 2010 Jul 21;30(29):9877-89. doi: 10.1523/JNEUROSCI.2056-10.2010.

Supplemental Content

Loading ...
Support Center